Fullerton Fund Management Co Ltd. purchased a new position in MetLife, Inc. (NYSE:MET – Free Report) during the second quarter, HoldingsChannel.com reports. The fund purchased 7,076 shares of the financial services provider’s stock, valued at approximately $569,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Quaker Wealth Management LLC raised its stake in MetLife by 198.2% during the second quarter. Quaker Wealth Management LLC now owns 333 shares of the financial services provider’s stock valued at $27,000 after buying an additional 672 shares during the last quarter. MTM Investment Management LLC bought a new position in shares of MetLife during the second quarter valued at $37,000. GFG Capital LLC purchased a new position in shares of MetLife in the 2nd quarter worth about $38,000. Abound Wealth Management boosted its stake in MetLife by 652.3% in the 2nd quarter. Abound Wealth Management now owns 489 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 424 shares in the last quarter. Finally, Legend Financial Advisors Inc. bought a new position in MetLife in the 2nd quarter worth about $40,000. Institutional investors own 94.99% of the company’s stock.
MetLife Trading Down 0.2%
NYSE:MET opened at $82.08 on Friday. The company has a current ratio of 0.18, a quick ratio of 0.18 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a 12 month low of $65.21 and a 12 month high of $88.09. The company has a market cap of $54.08 billion, a PE ratio of 15.46, a price-to-earnings-growth ratio of 0.79 and a beta of 0.76. The company has a 50 day simple moving average of $78.47 and a two-hundred day simple moving average of $78.76.
MetLife Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, December 9th. Shareholders of record on Tuesday, November 4th were paid a dividend of $0.5675 per share. This represents a $2.27 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date was Tuesday, November 4th. MetLife’s payout ratio is currently 42.75%.
Analyst Ratings Changes
MET has been the subject of several recent analyst reports. Wolfe Research raised shares of MetLife to a “strong-buy” rating in a report on Tuesday, September 16th. Morgan Stanley raised their price target on shares of MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Wells Fargo & Company lowered their price objective on MetLife from $96.00 to $92.00 and set an “overweight” rating on the stock in a research report on Friday, November 7th. Weiss Ratings reiterated a “hold (c+)” rating on shares of MetLife in a research note on Monday. Finally, Barclays lifted their target price on MetLife from $93.00 to $98.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, MetLife presently has an average rating of “Moderate Buy” and an average target price of $94.60.
View Our Latest Analysis on MetLife
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Synopsys Sees Bullish Shift as Ansys Integration Drives Growth
- A Deeper Look at Bid-Ask Spreads
- The Best Holiday Present You Can Give Yourself? Costco Stock
- The 3 Best Blue-Chip Stocks to Buy Now
- Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
